Sherman L. Matthew
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
17,275 |
111,354
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
9,725 |
57,385
(0%)
|
0%
|
|
0
|
Common Stock |
Dashyant Dhanak
|
EVP & Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
69,100 |
69,100
|
-
|
|
-
|
Stock Option (Right to Buy) |
L. Sherman Matthew
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 15.62 per share. |
15 Feb 2024 |
2,615 |
108,739
(0%)
|
0%
|
15.6 |
40,840
|
Common Stock |
Dashyant Dhanak
|
EVP & Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
17,275 |
158,175
(0%)
|
0%
|
|
0
|
Common Stock |
Kelly Thomas P.
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 15.62 per share. |
15 Feb 2024 |
3,010 |
80,350
(0%)
|
0%
|
15.6 |
47,009
|
Common Stock |
Hoerter Steven L.
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
298,100 |
298,100
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 15.62 per share. |
15 Feb 2024 |
2,267 |
68,031
(0%)
|
0%
|
15.6 |
35,405
|
Common Stock |
Kelly P. Thomas
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
17,275 |
83,360
(0%)
|
0%
|
|
0
|
Common Stock |
Pitman Jama
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
10,000 |
70,298
(0%)
|
0%
|
|
0
|
Common Stock |
Pitman Jama
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
9,725 |
60,298
(0%)
|
0%
|
|
0
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
69,100 |
69,100
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martin C. Daniel
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
38,900 |
38,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
C. Martin Daniel
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 15.62 per share. |
15 Feb 2024 |
2,267 |
55,118
(0%)
|
0%
|
15.6 |
35,405
|
Common Stock |
Kelly Thomas P.
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
69,100 |
69,100
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2024 |
38,900 |
38,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
L. Matthew Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 14.47 per share. |
16 Jan 2024 |
2,435 |
94,079
(0%)
|
0%
|
14.5 |
35,234
|
Common Stock |
Martin Daniel C.
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 14.47 per share. |
16 Jan 2024 |
1,624 |
47,660
(0%)
|
0%
|
14.5 |
23,499
|
Common Stock |
Walsh Dennis L.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
4,727 |
4,727
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 14.47 per share. |
16 Jan 2024 |
1,624 |
50,573
(0%)
|
0%
|
14.5 |
23,499
|
Common Stock |
S. Frank Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
4,727 |
4,727
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
4,727 |
4,727
|
-
|
|
-
|
Stock Option (Right to Buy) |
Squarer Ron
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2024 |
4,727 |
4,727
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 14.47 per share. |
16 Jan 2024 |
2,435 |
66,085
(0%)
|
0%
|
14.5 |
35,234
|
Common Stock |
P. Thomas Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2023 |
8,244 |
71,312
(0%)
|
0%
|
|
-
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 15.37 per share. |
12 Dec 2023 |
2,792 |
96,514
(0%)
|
0%
|
15.4 |
42,905
|
Common Stock |
L. Steven Hoerter
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 15.37 per share. |
12 Dec 2023 |
30,664 |
72,763
(0%)
|
0%
|
15.4 |
471,217
|
Common Stock |
C. Martin Daniel
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2023 |
5,576 |
51,011
(0%)
|
0%
|
|
-
|
Common Stock |
Matthew Sherman L.
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2023 |
8,244 |
99,306
(0%)
|
0%
|
|
-
|
Common Stock |
C. Martin Daniel
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 15.37 per share. |
12 Dec 2023 |
1,727 |
49,284
(0%)
|
0%
|
15.4 |
26,539
|
Common Stock |
Pitman Jama
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 15.37 per share. |
12 Dec 2023 |
1,662 |
52,197
(0%)
|
0%
|
15.4 |
25,540
|
Common Stock |
P. Kelly Thomas
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 15.37 per share. |
12 Dec 2023 |
2,792 |
68,520
(0%)
|
0%
|
15.4 |
42,905
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2023 |
62,500 |
103,427
(0%)
|
0%
|
|
-
|
Common Stock |
Jama Pitman
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2023 |
5,576 |
53,859
(0%)
|
0%
|
|
-
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James A. Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward J. Benz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John R. Martin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jun 2023 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
16 Jun 2023 |
1,655 |
57,140
(0%)
|
0%
|
14.4 |
23,835
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
16 Jun 2023 |
1,655 |
87,686
(0%)
|
0%
|
14.4 |
23,835
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
16 Jun 2023 |
1,655 |
57,158
(0%)
|
0%
|
14.4 |
23,835
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
16 Jun 2023 |
1,238 |
58,413
(0%)
|
0%
|
14.4 |
17,829
|
Common Stock |
Jama Pitman
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 14.40 per share. |
16 Jun 2023 |
1,238 |
43,812
(0%)
|
0%
|
14.4 |
17,829
|
Common Stock |
Frank S. Friedman
|
Director |
Purchase of securities on an exchange or from another person at price $ 13.88 per share. |
08 Jun 2023 |
10,000 |
10,000
(0%)
|
0%
|
13.9 |
138,828
|
Common Stock |
Dennis L. Walsh
|
Director |
Purchase of securities on an exchange or from another person at price $ 13.86 per share. |
10 May 2023 |
11,000 |
11,000
(0%)
|
0%
|
13.9 |
152,416
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 15.57 per share. |
21 Mar 2023 |
7,500 |
0
(0%)
|
0%
|
15.6 |
116,782
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
65,900 |
65,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
16,488 |
60,165
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
15 Feb 2023 |
1,370 |
58,795
(0%)
|
0%
|
15.1 |
20,686
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
15 Feb 2023 |
971 |
88,145
(0%)
|
0%
|
15.1 |
14,661
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
65,900 |
65,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
16,488 |
89,116
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
65,900 |
65,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
16,488 |
60,183
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
15 Feb 2023 |
1,370 |
58,813
(0%)
|
0%
|
15.1 |
20,686
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
44,600 |
44,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
15 Feb 2023 |
1,159 |
58,381
(0%)
|
0%
|
15.1 |
17,500
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
11,151 |
59,540
(0%)
|
0%
|
|
0
|
Common Stock |
Jama Pitman
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
44,600 |
44,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 15.10 per share. |
15 Feb 2023 |
1,159 |
45,050
(0%)
|
0%
|
15.1 |
17,500
|
Common Stock |
Jama Pitman
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2023 |
11,151 |
46,209
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 16.00 per share. |
14 Feb 2023 |
30,045 |
7,500
(0%)
|
0%
|
16 |
480,720
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Feb 2023 |
250,000 |
250,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
3,269 |
3,269
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 21.24 per share. |
17 Jan 2023 |
2,403 |
43,677
(0%)
|
0%
|
21.2 |
51,043
|
Common Stock |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
3,269 |
3,269
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
3,269 |
3,269
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 21.24 per share. |
17 Jan 2023 |
2,403 |
72,628
(0%)
|
0%
|
21.2 |
51,043
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.24 per share. |
17 Jan 2023 |
2,403 |
43,695
(0%)
|
0%
|
21.2 |
51,043
|
Common Stock |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
3,269 |
3,269
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 21.24 per share. |
17 Jan 2023 |
1,603 |
48,389
(0%)
|
0%
|
21.2 |
34,050
|
Common Stock |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
3,269 |
3,269
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 21.24 per share. |
17 Jan 2023 |
1,603 |
35,058
(0%)
|
0%
|
21.2 |
34,050
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.73 per share. |
03 Oct 2022 |
2,587 |
74,297
(0%)
|
0%
|
18.7 |
48,455
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward J. Benz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
John R. Martin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
18,500 |
18,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 10.75 per share. |
16 Jun 2022 |
1,768 |
46,080
(0%)
|
0%
|
10.8 |
19,006
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 10.75 per share. |
16 Jun 2022 |
1,768 |
76,884
(0%)
|
0%
|
10.8 |
19,006
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 10.75 per share. |
16 Jun 2022 |
1,768 |
46,098
(0%)
|
0%
|
10.8 |
19,006
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 10.75 per share. |
16 Jun 2022 |
1,311 |
49,521
(0%)
|
0%
|
10.7 |
14,093
|
Common Stock |
Jama Pitman
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 10.75 per share. |
16 Jun 2022 |
1,298 |
36,661
(0%)
|
0%
|
10.8 |
13,954
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.11 per share. |
21 Mar 2022 |
3,150 |
37,545
(0%)
|
0%
|
9.1 |
28,697
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 9.05 per share. |
16 Feb 2022 |
1,368 |
47,848
(0%)
|
0%
|
9.0 |
12,380
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 9.05 per share. |
16 Feb 2022 |
984 |
76,790
(0%)
|
0%
|
9.0 |
8,905
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 9.05 per share. |
16 Feb 2022 |
1,366 |
47,866
(0%)
|
0%
|
9.0 |
12,362
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 9.05 per share. |
16 Feb 2022 |
1,146 |
48,668
(0%)
|
0%
|
9.0 |
10,371
|
Common Stock |
Jama Pitman
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 9.05 per share. |
16 Feb 2022 |
1,146 |
37,959
(0%)
|
0%
|
9.0 |
10,371
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
20,500 |
49,216
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
82,000 |
82,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
415,000 |
415,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
82,000 |
82,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
20,500 |
77,774
(0%)
|
0%
|
|
0
|
Common Stock |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
82,000 |
82,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
20,500 |
49,232
(0%)
|
0%
|
|
0
|
Common Stock |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel C. Martin
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
13,667 |
49,814
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
54,667 |
54,667
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
9,570 |
9,570
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jama Pitman
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
13,667 |
39,105
(0%)
|
0%
|
|
0
|
Common Stock |
Jama Pitman
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
54,667 |
54,667
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 33.17 per share. |
04 Oct 2021 |
2,659 |
46,029
(0%)
|
0%
|
33.2 |
88,199
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward J. Benz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John R. Martin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
03 May 2021 |
5,646 |
8,000
(0%)
|
0%
|
4.0 |
22,302
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 May 2021 |
5,646 |
193,752
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 May 2021 |
2,354 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 46.75 per share. |
03 May 2021 |
300 |
0
(0%)
|
0%
|
46.8 |
14,025
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 46.07 per share. |
03 May 2021 |
7,700 |
300
(0%)
|
0%
|
46.1 |
354,718
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
03 May 2021 |
2,354 |
2,354
(0%)
|
0%
|
1.9 |
4,449
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 46.13 per share. |
19 Apr 2021 |
4,000 |
1,300
(0%)
|
0%
|
46.1 |
184,518
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Apr 2021 |
1,700 |
22,150
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Apr 2021 |
5,300 |
23,850
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 45.60 per share. |
19 Apr 2021 |
1,700 |
0
(0%)
|
0%
|
45.6 |
77,514
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
19 Apr 2021 |
1,700 |
1,700
(0%)
|
0%
|
4.0 |
6,715
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 46.66 per share. |
19 Apr 2021 |
1,300 |
0
(0%)
|
0%
|
46.7 |
60,662
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
19 Apr 2021 |
5,300 |
5,300
(0%)
|
0%
|
4.0 |
20,935
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 43.70 per share. |
12 Apr 2021 |
9,483 |
5,217
(0%)
|
0%
|
43.7 |
414,370
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Apr 2021 |
14,700 |
29,150
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 44.09 per share. |
12 Apr 2021 |
5,217 |
0
(0%)
|
0%
|
44.1 |
230,040
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
12 Apr 2021 |
14,700 |
14,700
(0%)
|
0%
|
4.0 |
58,065
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 44.80 per share. |
01 Apr 2021 |
2,100 |
5,900
(0%)
|
0%
|
44.8 |
94,074
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2021 |
8,000 |
2,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 46.72 per share. |
01 Apr 2021 |
906 |
0
(0%)
|
0%
|
46.7 |
42,328
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 45.69 per share. |
01 Apr 2021 |
4,994 |
906
(0%)
|
0%
|
45.7 |
228,169
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Apr 2021 |
8,000 |
8,000
(0%)
|
0%
|
1.9 |
15,120
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.39 per share. |
18 Mar 2021 |
700 |
43,145
(0%)
|
0%
|
42.4 |
29,672
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.20 per share. |
18 Mar 2021 |
2,450 |
40,695
(0%)
|
0%
|
43.2 |
105,828
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2021 |
8,000 |
10,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 43.94 per share. |
01 Mar 2021 |
6,896 |
1,104
(0%)
|
0%
|
43.9 |
302,983
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Mar 2021 |
8,000 |
8,000
(0%)
|
0%
|
1.9 |
15,120
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 44.68 per share. |
01 Mar 2021 |
1,104 |
0
(0%)
|
0%
|
44.7 |
49,324
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 48.87 per share. |
16 Feb 2021 |
524 |
6,516
(0%)
|
0%
|
48.9 |
25,608
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
49,900 |
49,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
11,100 |
17,616
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
210,000 |
210,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
49,900 |
49,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
11,100 |
48,386
(0%)
|
0%
|
|
0
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 48.87 per share. |
16 Feb 2021 |
132 |
37,286
(0%)
|
0%
|
48.9 |
6,451
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
49,900 |
49,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Feb 2021 |
11,100 |
17,632
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 48.87 per share. |
16 Feb 2021 |
508 |
6,532
(0%)
|
0%
|
48.9 |
24,826
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Feb 2021 |
8,000 |
8,000
(0%)
|
0%
|
1.9 |
15,120
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Feb 2021 |
8,000 |
18,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 45.96 per share. |
01 Feb 2021 |
800 |
0
(0%)
|
0%
|
46.0 |
36,770
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 45.64 per share. |
01 Feb 2021 |
4,518 |
800
(0%)
|
0%
|
45.6 |
206,188
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 44.34 per share. |
01 Feb 2021 |
2,682 |
5,318
(0%)
|
0%
|
44.3 |
118,915
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
21 Jan 2021 |
1,078 |
43,845
(0%)
|
0%
|
25.4 |
27,381
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Jan 2021 |
1,078 |
395,735
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
1,563 |
1,563
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 50.21 per share. |
15 Jan 2021 |
6,400 |
600
(0%)
|
0%
|
50.2 |
321,373
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 51.11 per share. |
15 Jan 2021 |
600 |
0
(0%)
|
0%
|
51.1 |
30,666
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
15 Jan 2021 |
7,000 |
7,000
(0%)
|
0%
|
4.0 |
27,650
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
7,000 |
43,850
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
1,563 |
1,563
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
1,563 |
1,563
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jan 2021 |
19,000 |
26,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
04 Jan 2021 |
19,000 |
19,000
(0%)
|
0%
|
1.9 |
35,910
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.73 per share. |
04 Jan 2021 |
8,517 |
2,794
(0%)
|
0%
|
56.7 |
483,175
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.37 per share. |
04 Jan 2021 |
2,794 |
0
(0%)
|
0%
|
57.4 |
160,294
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 55.80 per share. |
04 Jan 2021 |
7,689 |
11,311
(0%)
|
0%
|
55.8 |
429,028
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.43 per share. |
09 Dec 2020 |
207 |
37,418
(0%)
|
0%
|
34.4 |
7,127
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2020 |
207 |
147,096
|
-
|
|
-
|
Stock Option (Right to buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 62.94 per share. |
01 Dec 2020 |
200 |
0
(0%)
|
0%
|
62.9 |
12,588
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2020 |
19,000 |
45,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 61.16 per share. |
01 Dec 2020 |
11,309 |
1,211
(0%)
|
0%
|
61.2 |
691,692
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Dec 2020 |
19,000 |
19,000
(0%)
|
0%
|
1.9 |
35,910
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 60.23 per share. |
01 Dec 2020 |
6,480 |
12,520
(0%)
|
0%
|
60.2 |
390,315
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 61.87 per share. |
01 Dec 2020 |
1,011 |
200
(0%)
|
0%
|
61.9 |
62,547
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Nov 2020 |
2,697 |
147,303
|
-
|
|
-
|
Stock Option (Right to buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.43 per share. |
16 Nov 2020 |
2,697 |
37,211
(0%)
|
0%
|
34.4 |
92,858
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 64.67 per share. |
04 Nov 2020 |
12,169 |
2,831
(0%)
|
0%
|
64.7 |
786,953
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Nov 2020 |
15,000 |
64,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 65.36 per share. |
04 Nov 2020 |
2,831 |
0
(0%)
|
0%
|
65.4 |
185,034
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
04 Nov 2020 |
15,000 |
15,000
(0%)
|
0%
|
1.9 |
28,350
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.03 per share. |
02 Nov 2020 |
7,205 |
16,110
(0%)
|
0%
|
57.0 |
410,911
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Nov 2020 |
23,315 |
79,354
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.53 per share. |
02 Nov 2020 |
3,499 |
0
(0%)
|
0%
|
58.5 |
204,805
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.74 per share. |
02 Nov 2020 |
12,611 |
3,499
(0%)
|
0%
|
57.7 |
728,211
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Nov 2020 |
23,315 |
23,315
(0%)
|
0%
|
1.9 |
44,065
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Oct 2020 |
23,541 |
23,541
(0%)
|
0%
|
1.9 |
44,492
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Oct 2020 |
23,541 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 55.43 per share. |
09 Oct 2020 |
200 |
0
(0%)
|
0%
|
55.4 |
11,086
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 54.53 per share. |
09 Oct 2020 |
3,971 |
200
(0%)
|
0%
|
54.5 |
216,531
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 53.35 per share. |
09 Oct 2020 |
19,370 |
4,171
(0%)
|
0%
|
53.4 |
1,033,451
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.15 per share. |
02 Oct 2020 |
2,632 |
34,128
(0%)
|
0%
|
51.1 |
134,618
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2020 |
104,635 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2020 |
20,365 |
102,669
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 51.98 per share. |
01 Oct 2020 |
23,886 |
0
(0%)
|
0%
|
52.0 |
1,241,597
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 51.52 per share. |
01 Oct 2020 |
101,114 |
23,886
(0%)
|
0%
|
51.5 |
5,208,888
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Oct 2020 |
20,365 |
125,000
(0%)
|
0%
|
1.9 |
38,490
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Oct 2020 |
104,635 |
104,635
(0%)
|
0%
|
1.9 |
197,760
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 50.01 per share. |
14 Sep 2020 |
3,000 |
7,040
(0%)
|
0%
|
50.0 |
150,036
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
14 Sep 2020 |
3,000 |
10,040
(0%)
|
0%
|
1.9 |
5,670
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Sep 2020 |
3,000 |
47,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 47.71 per share. |
08 Sep 2020 |
3,000 |
7,040
(0%)
|
0%
|
47.7 |
143,126
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
08 Sep 2020 |
3,000 |
10,040
(0%)
|
0%
|
1.9 |
5,670
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 46.55 per share. |
08 Sep 2020 |
1,500 |
7,040
(0%)
|
0%
|
46.6 |
69,825
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 45.23 per share. |
08 Sep 2020 |
3,700 |
8,540
(0%)
|
0%
|
45.2 |
167,349
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
08 Sep 2020 |
6,000 |
13,040
(0%)
|
0%
|
1.9 |
11,340
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 44.70 per share. |
08 Sep 2020 |
800 |
12,240
(0%)
|
0%
|
44.7 |
35,756
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2020 |
3,000 |
50,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Sep 2020 |
6,000 |
53,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Aug 2020 |
187 |
396,813
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
20 Aug 2020 |
187 |
42,767
(0%)
|
0%
|
25.4 |
4,750
|
Common Stock |
Daniel Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Aug 2020 |
9,029 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
10 Aug 2020 |
9,029 |
237,475
(0%)
|
0%
|
1.9 |
17,065
|
Common Stock |
Daniel Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Jul 2020 |
130,000 |
9,029
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
22 Jul 2020 |
130,000 |
228,446
(0%)
|
0%
|
1.9 |
245,700
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
20 Jul 2020 |
188 |
42,580
(0%)
|
0%
|
25.4 |
4,775
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jul 2020 |
188 |
397,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jul 2020 |
723 |
723
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 57.02 per share. |
09 Jul 2020 |
301 |
0
(0%)
|
0%
|
57.0 |
17,162
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 56.24 per share. |
09 Jul 2020 |
1,829 |
301
(0%)
|
0%
|
56.2 |
102,866
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 55.15 per share. |
09 Jul 2020 |
9,050 |
2,130
(0%)
|
0%
|
55.2 |
499,110
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 54.65 per share. |
09 Jul 2020 |
12,361 |
11,180
(0%)
|
0%
|
54.6 |
675,495
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Jul 2020 |
16,324 |
16,324
(0%)
|
0%
|
1.9 |
30,852
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Jul 2020 |
7,217 |
23,541
(0%)
|
0%
|
1.9 |
13,640
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jul 2020 |
7,217 |
23,541
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jul 2020 |
16,324 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Jul 2020 |
27,544 |
27,544
(0%)
|
0%
|
1.9 |
52,058
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2020 |
27,544 |
104,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2020 |
48,245 |
132,179
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2020 |
49,211 |
180,424
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.13 per share. |
01 Jul 2020 |
350 |
0
(0%)
|
0%
|
57.1 |
19,996
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.55 per share. |
01 Jul 2020 |
4,283 |
350
(0%)
|
0%
|
56.6 |
242,219
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 55.52 per share. |
01 Jul 2020 |
6,867 |
4,633
(0%)
|
0%
|
55.5 |
381,273
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 54.69 per share. |
01 Jul 2020 |
16,044 |
11,500
(0%)
|
0%
|
54.7 |
877,384
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.96 per share. |
01 Jul 2020 |
800 |
0
(0%)
|
0%
|
58.0 |
46,366
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.85 per share. |
01 Jul 2020 |
37,100 |
800
(0%)
|
0%
|
56.8 |
2,109,128
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.01 per share. |
01 Jul 2020 |
10,345 |
37,900
(0%)
|
0%
|
56.0 |
579,471
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Jul 2020 |
48,245 |
48,245
(0%)
|
0%
|
1.9 |
91,183
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 60.58 per share. |
01 Jul 2020 |
200 |
0
(0%)
|
0%
|
60.6 |
12,116
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 59.97 per share. |
01 Jul 2020 |
14,016 |
200
(0%)
|
0%
|
60.0 |
840,524
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 59.02 per share. |
01 Jul 2020 |
8,632 |
14,216
(0%)
|
0%
|
59.0 |
509,503
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.22 per share. |
01 Jul 2020 |
26,363 |
22,848
(0%)
|
0%
|
58.2 |
1,534,746
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Jul 2020 |
49,211 |
49,211
(0%)
|
0%
|
1.9 |
93,009
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jun 2020 |
187 |
397,188
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
18 Jun 2020 |
187 |
42,392
(0%)
|
0%
|
25.4 |
4,750
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward J. Benz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John R. Martin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Jun 2020 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.73 per share. |
03 Jun 2020 |
6,365 |
6,365
(0%)
|
0%
|
25.7 |
163,771
|
Common Stock |
Patricia L. Allen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jun 2020 |
5,635 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jun 2020 |
6,365 |
5,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.73 per share. |
03 Jun 2020 |
5,635 |
5,635
(0%)
|
0%
|
25.7 |
144,989
|
Common Stock |
Patricia L. Allen
|
Director |
Sale of securities on an exchange or to another person at price $ 59.14 per share. |
03 Jun 2020 |
6,365 |
0
(0%)
|
0%
|
59.1 |
376,450
|
Common Stock |
Patricia L. Allen
|
Director |
Sale of securities on an exchange or to another person at price $ 55.90 per share. |
03 Jun 2020 |
5,635 |
0
(0%)
|
0%
|
55.9 |
314,999
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
188 |
397,375
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
28 May 2020 |
188 |
42,205
(0%)
|
0%
|
25.4 |
4,775
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 55.08 per share. |
11 May 2020 |
9,395 |
9,645
(0%)
|
0%
|
55.1 |
517,516
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 May 2020 |
12,000 |
59,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 55.56 per share. |
11 May 2020 |
2,605 |
7,040
(0%)
|
0%
|
55.6 |
144,724
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
11 May 2020 |
12,000 |
19,040
(0%)
|
0%
|
1.9 |
22,680
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Apr 2020 |
25,000 |
229,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
28 Apr 2020 |
25,000 |
25,000
(0%)
|
0%
|
1.9 |
47,250
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 55.12 per share. |
28 Apr 2020 |
1,200 |
23,800
(0%)
|
0%
|
55.1 |
66,140
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.31 per share. |
28 Apr 2020 |
11,819 |
11,981
(0%)
|
0%
|
56.3 |
665,576
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.96 per share. |
28 Apr 2020 |
3,981 |
8,000
(0%)
|
0%
|
57.0 |
226,773
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.00 per share. |
28 Apr 2020 |
8,000 |
0
(0%)
|
0%
|
58 |
464,000
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Apr 2020 |
187 |
397,563
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
21 Apr 2020 |
187 |
42,017
(0%)
|
0%
|
25.4 |
4,750
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
17 Apr 2020 |
23,892 |
23,892
(0%)
|
0%
|
1.9 |
45,156
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Apr 2020 |
23,892 |
254,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 46.67 per share. |
17 Apr 2020 |
23,892 |
0
(0%)
|
0%
|
46.7 |
1,115,150
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 46.71 per share. |
14 Apr 2020 |
1,108 |
0
(0%)
|
0%
|
46.7 |
51,753
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Apr 2020 |
1,108 |
278,527
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
14 Apr 2020 |
1,108 |
1,108
(0%)
|
0%
|
1.9 |
2,094
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 42.97 per share. |
09 Apr 2020 |
6,373 |
17,169
(0%)
|
0%
|
43.0 |
273,847
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Apr 2020 |
23,542 |
16,324
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 45.88 per share. |
09 Apr 2020 |
536 |
0
(0%)
|
0%
|
45.9 |
24,594
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 44.18 per share. |
09 Apr 2020 |
11,012 |
536
(0%)
|
0%
|
44.2 |
486,483
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 43.93 per share. |
09 Apr 2020 |
5,621 |
11,548
(0%)
|
0%
|
43.9 |
246,916
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Apr 2020 |
23,542 |
23,542
(0%)
|
0%
|
1.9 |
44,494
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 37.29 per share. |
01 Apr 2020 |
58,682 |
16,318
(0%)
|
0%
|
37.3 |
2,188,252
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2020 |
75,000 |
279,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 40.08 per share. |
01 Apr 2020 |
2,166 |
0
(0%)
|
0%
|
40.1 |
86,813
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 39.29 per share. |
01 Apr 2020 |
2,480 |
2,166
(0%)
|
0%
|
39.3 |
97,439
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 38.13 per share. |
01 Apr 2020 |
11,672 |
4,646
(0%)
|
0%
|
38.1 |
445,053
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Apr 2020 |
75,000 |
75,000
(0%)
|
0%
|
1.9 |
141,750
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.40 per share. |
18 Mar 2020 |
2,250 |
54,250
(0%)
|
0%
|
25.4 |
57,150
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Mar 2020 |
2,250 |
397,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.98 per share. |
18 Mar 2020 |
520 |
41,830
(0%)
|
0%
|
40.0 |
20,790
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.22 per share. |
18 Mar 2020 |
2,164 |
42,350
(0%)
|
0%
|
39.2 |
84,872
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.26 per share. |
18 Mar 2020 |
4,230 |
44,514
(0%)
|
0%
|
38.3 |
161,840
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.88 per share. |
18 Mar 2020 |
1,012 |
48,744
(0%)
|
0%
|
36.9 |
37,323
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.78 per share. |
18 Mar 2020 |
4,494 |
49,756
(0%)
|
0%
|
35.8 |
160,795
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
42,190 |
42,190
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
7,040 |
7,040
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Hoerter
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
180,000 |
180,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
1,760 |
36,760
(0%)
|
0%
|
|
0
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
10,520 |
10,520
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
42,190 |
42,190
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel Flynn
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Feb 2020 |
7,040 |
98,446
(0%)
|
0%
|
|
0
|
Common Stock |
Patricia L. Allen
|
Director |
Sale of securities on an exchange or to another person at price $ 65.93 per share. |
24 Jan 2020 |
17,804 |
7,196
(0%)
|
0%
|
65.9 |
1,173,871
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2020 |
25,000 |
10,233
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patricia L. Allen
|
Director |
Sale of securities on an exchange or to another person at price $ 67.36 per share. |
24 Jan 2020 |
700 |
0
(0%)
|
0%
|
67.4 |
47,151
|
Common Stock |
Patricia L. Allen
|
Director |
Sale of securities on an exchange or to another person at price $ 66.55 per share. |
24 Jan 2020 |
6,496 |
700
(0%)
|
0%
|
66.5 |
432,303
|
Common Stock |
Patricia L. Allen
|
Director |
|
24 Jan 2020 |
25,000 |
25,000
(0%)
|
0%
|
4.0 |
98,750
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.10 per share. |
22 Jan 2020 |
26,999 |
43,999
(0%)
|
0%
|
36.1 |
974,664
|
Common Stock |
Daniel C. Martin
|
Chief Commercial Officer |
|
22 Jan 2020 |
26,999 |
63,001
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 67.18 per share. |
22 Jan 2020 |
26,999 |
17,000
(0%)
|
0%
|
67.2 |
1,813,709
|
Common Stock |
Daniel Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Jan 2020 |
10,106 |
4,944
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
15 Jan 2020 |
12,023 |
12,023
(0%)
|
0%
|
4.0 |
47,491
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2020 |
3,011 |
150,344
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2020 |
12,023 |
153,355
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 65.40 per share. |
15 Jan 2020 |
3,011 |
0
(0%)
|
0%
|
65.4 |
196,932
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
15 Jan 2020 |
3,011 |
3,011
(0%)
|
0%
|
3.9 |
11,893
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 65.23 per share. |
15 Jan 2020 |
12,023 |
0
(0%)
|
0%
|
65.2 |
784,274
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 60.02 per share. |
07 Jan 2020 |
1,650 |
0
(0%)
|
0%
|
60.0 |
99,035
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
07 Jan 2020 |
1,650 |
1,650
(0%)
|
0%
|
4.0 |
6,518
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jan 2020 |
12,281 |
165,378
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jan 2020 |
1,650 |
177,659
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 60.11 per share. |
07 Jan 2020 |
12,281 |
0
(0%)
|
0%
|
60.1 |
738,272
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
07 Jan 2020 |
12,281 |
12,281
(0%)
|
0%
|
4.0 |
48,510
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
7,641 |
7,641
(0%)
|
0%
|
1.9 |
14,441
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
7,641 |
75,367
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 58.74 per share. |
02 Jan 2020 |
100 |
0
(0%)
|
0%
|
58.7 |
5,874
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 58.14 per share. |
02 Jan 2020 |
966 |
100
(0%)
|
0%
|
58.1 |
56,166
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 57.22 per share. |
02 Jan 2020 |
2,793 |
1,066
(0%)
|
0%
|
57.2 |
159,825
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
4,359 |
4,359
(0%)
|
0%
|
1.9 |
8,239
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 56.26 per share. |
02 Jan 2020 |
500 |
3,859
(0%)
|
0%
|
56.3 |
28,128
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 62.25 per share. |
02 Jan 2020 |
100 |
0
(0%)
|
0%
|
62.3 |
6,225
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 59.48 per share. |
02 Jan 2020 |
200 |
100
(0%)
|
0%
|
59.5 |
11,896
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 58.16 per share. |
02 Jan 2020 |
1,981 |
300
(0%)
|
0%
|
58.2 |
115,219
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 57.54 per share. |
02 Jan 2020 |
5,360 |
2,281
(0%)
|
0%
|
57.5 |
308,408
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
4,359 |
71,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.21 per share. |
02 Jan 2020 |
18,903 |
8,531
(0%)
|
0%
|
57.2 |
1,081,384
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 56.01 per share. |
02 Jan 2020 |
3,988 |
27,434
(0%)
|
0%
|
56.0 |
223,358
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
31,422 |
31,422
(0%)
|
0%
|
1.9 |
59,388
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 61.98 per share. |
02 Jan 2020 |
1,034 |
0
(0%)
|
0%
|
62.0 |
64,088
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 60.82 per share. |
02 Jan 2020 |
1,000 |
1,034
(0%)
|
0%
|
60.8 |
60,819
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 59.40 per share. |
02 Jan 2020 |
2,731 |
2,034
(0%)
|
0%
|
59.4 |
162,229
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.08 per share. |
02 Jan 2020 |
33,045 |
4,765
(0%)
|
0%
|
58.1 |
1,919,300
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 57.50 per share. |
02 Jan 2020 |
55,768 |
37,810
(0%)
|
0%
|
57.5 |
3,206,677
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
93,578 |
93,578
(0%)
|
0%
|
1.9 |
176,862
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
31,422 |
354,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
93,578 |
386,057
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.69 per share. |
02 Jan 2020 |
1,200 |
0
(0%)
|
0%
|
58.7 |
70,430
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 58.08 per share. |
02 Jan 2020 |
7,331 |
1,200
(0%)
|
0%
|
58.1 |
425,751
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
15,553 |
15,553
(0%)
|
0%
|
1.9 |
29,395
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
7,989 |
39,866
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
15,553 |
47,855
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 58.72 per share. |
02 Jan 2020 |
200 |
0
(0%)
|
0%
|
58.7 |
11,744
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 58.17 per share. |
02 Jan 2020 |
1,810 |
200
(0%)
|
0%
|
58.2 |
105,282
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 57.21 per share. |
02 Jan 2020 |
5,250 |
2,010
(0%)
|
0%
|
57.2 |
300,372
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 55.96 per share. |
02 Jan 2020 |
729 |
7,260
(0%)
|
0%
|
56.0 |
40,797
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
02 Jan 2020 |
7,989 |
7,989
(0%)
|
0%
|
1.9 |
15,099
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 61.87 per share. |
02 Jan 2020 |
300 |
0
(0%)
|
0%
|
61.9 |
18,561
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 59.38 per share. |
02 Jan 2020 |
365 |
300
(0%)
|
0%
|
59.4 |
21,675
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 58.08 per share. |
02 Jan 2020 |
5,347 |
665
(0%)
|
0%
|
58.1 |
310,567
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 57.51 per share. |
02 Jan 2020 |
9,541 |
6,012
(0%)
|
0%
|
57.5 |
548,665
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
02 Jan 2020 |
16,137 |
16,137
(0%)
|
0%
|
3.9 |
63,741
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2020 |
16,137 |
179,309
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 62.25 per share. |
02 Jan 2020 |
400 |
0
(0%)
|
0%
|
62.3 |
24,900
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 61.58 per share. |
02 Jan 2020 |
800 |
400
(0%)
|
0%
|
61.6 |
49,266
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 60.58 per share. |
02 Jan 2020 |
800 |
1,200
(0%)
|
0%
|
60.6 |
48,463
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 59.48 per share. |
02 Jan 2020 |
2,103 |
2,000
(0%)
|
0%
|
59.5 |
125,087
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 58.38 per share. |
02 Jan 2020 |
3,529 |
4,103
(0%)
|
0%
|
58.4 |
206,039
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 57.74 per share. |
02 Jan 2020 |
8,505 |
7,632
(0%)
|
0%
|
57.7 |
491,117
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 Dec 2019 |
40,000 |
83,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
23 Dec 2019 |
40,000 |
40,000
(0%)
|
0%
|
1.9 |
75,600
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 68.21 per share. |
23 Dec 2019 |
40,000 |
0
(0%)
|
0%
|
68.2 |
2,728,368
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 60.00 per share. |
12 Dec 2019 |
31,029 |
35,750
(0%)
|
0%
|
60 |
1,861,740
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Dec 2019 |
15,034 |
195,446
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
12 Dec 2019 |
15,034 |
15,034
(0%)
|
0%
|
3.9 |
59,384
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 60.00 per share. |
12 Dec 2019 |
15,034 |
0
(0%)
|
0%
|
60 |
902,040
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 55.00 per share. |
09 Dec 2019 |
30,175 |
24,500
(0%)
|
0%
|
55 |
1,659,625
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Dec 2019 |
30,175 |
54,675
(0%)
|
0%
|
1.9 |
57,031
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2019 |
30,175 |
136,649
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 55.00 per share. |
09 Dec 2019 |
93,930 |
24,500
(0%)
|
0%
|
55 |
5,166,150
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Dec 2019 |
93,930 |
118,430
(0%)
|
0%
|
1.9 |
177,528
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 55.00 per share. |
09 Dec 2019 |
28,822 |
24,500
(0%)
|
0%
|
55 |
1,585,210
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
09 Dec 2019 |
28,822 |
53,322
(0%)
|
0%
|
1.9 |
54,474
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2019 |
93,930 |
13,897
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2019 |
28,822 |
107,827
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 55.00 per share. |
09 Dec 2019 |
11,647 |
0
(0%)
|
0%
|
55 |
640,585
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Dec 2019 |
11,647 |
210,480
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Dec 2019 |
3,387 |
222,127
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
09 Dec 2019 |
3,387 |
3,387
(0%)
|
0%
|
4.0 |
13,379
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
09 Dec 2019 |
11,647 |
11,647
(0%)
|
0%
|
4.0 |
46,006
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 55.00 per share. |
09 Dec 2019 |
3,387 |
0
(0%)
|
0%
|
55 |
186,285
|
Common Stock |
Ron Squarer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2019 |
21,900 |
21,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
Christopher J. Morl
|
Chief Business Officer |
Sale of securities on an exchange or to another person at price $ 50.00 per share. |
03 Dec 2019 |
15,034 |
0
(0%)
|
0%
|
50.0 |
751,763
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Dec 2019 |
15,034 |
15,034
(0%)
|
0%
|
|
0
|
Common Stock |
Christopher J. Morl
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Dec 2019 |
15,034 |
225,514
|
-
|
|
-
|
Stock Option (Right to Buy) |
Frank S. Friedman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
23,400 |
23,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Nov 2019 |
9,742 |
310,009
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Nov 2019 |
143,185 |
166,824
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 48.01 per share. |
08 Nov 2019 |
143,185 |
24,500
(0%)
|
0%
|
48.0 |
6,874,870
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
08 Nov 2019 |
143,185 |
167,685
(0%)
|
0%
|
1.9 |
270,620
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 48.00 per share. |
08 Nov 2019 |
9,742 |
24,500
(0%)
|
0%
|
48 |
467,616
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
08 Nov 2019 |
9,742 |
34,242
(0%)
|
0%
|
1.9 |
18,412
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Nov 2019 |
7,500 |
7,500
(0%)
|
0%
|
1.9 |
14,175
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2019 |
7,500 |
479,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 45.02 per share. |
01 Nov 2019 |
7,500 |
0
(0%)
|
0%
|
45.0 |
337,646
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2019 |
25,000 |
63,408
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 45.07 per share. |
01 Nov 2019 |
25,000 |
0
(0%)
|
0%
|
45.1 |
1,126,823
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 Nov 2019 |
25,000 |
25,000
(0%)
|
0%
|
1.9 |
47,250
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 40.00 per share. |
28 Oct 2019 |
3,750 |
0
(0%)
|
0%
|
40.0 |
150,010
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Oct 2019 |
3,750 |
123,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
28 Oct 2019 |
3,750 |
3,750
(0%)
|
0%
|
1.9 |
7,088
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 40.00 per share. |
28 Oct 2019 |
29,820 |
24,500
(0%)
|
0%
|
40 |
1,192,800
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Oct 2019 |
29,820 |
319,751
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
28 Oct 2019 |
29,820 |
54,320
(0%)
|
0%
|
1.9 |
56,360
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Oct 2019 |
35,000 |
35,000
(0%)
|
0%
|
|
0
|
Common Stock |
Matthew L. Sherman
|
EVP & Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Oct 2019 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Daniel C. Martin
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 35.56 per share. |
19 Sep 2019 |
3,000 |
17,000
(0%)
|
0%
|
35.6 |
106,688
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 34.80 per share. |
11 Sep 2019 |
8,160 |
8,160
(0%)
|
0%
|
34.8 |
283,972
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2019 |
11,250 |
126,758
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 35.43 per share. |
11 Sep 2019 |
3,090 |
0
(0%)
|
0%
|
35.4 |
109,468
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
11 Sep 2019 |
11,250 |
11,250
(0%)
|
0%
|
1.9 |
21,263
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 35.41 per share. |
11 Sep 2019 |
6,151 |
0
(0%)
|
0%
|
35.4 |
217,789
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
11 Sep 2019 |
22,500 |
22,500
(0%)
|
0%
|
1.9 |
42,525
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2019 |
22,500 |
487,135
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 34.81 per share. |
11 Sep 2019 |
16,349 |
6,151
(0%)
|
0%
|
34.8 |
569,043
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Sep 2019 |
7,500 |
509,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
03 Sep 2019 |
7,500 |
7,500
(0%)
|
0%
|
1.9 |
14,175
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 36.26 per share. |
03 Sep 2019 |
7,500 |
0
(0%)
|
0%
|
36.3 |
271,975
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
13 Aug 2019 |
11,250 |
11,250
(0%)
|
0%
|
1.9 |
21,263
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 40.69 per share. |
13 Aug 2019 |
7,264 |
3,986
(0%)
|
0%
|
40.7 |
295,568
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 42.25 per share. |
13 Aug 2019 |
3,586 |
400
(0%)
|
0%
|
42.3 |
151,521
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 42.92 per share. |
13 Aug 2019 |
400 |
0
(0%)
|
0%
|
42.9 |
17,167
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Aug 2019 |
11,250 |
138,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
13 Aug 2019 |
22,500 |
22,500
(0%)
|
0%
|
1.9 |
42,525
|
Common Stock |
Michael Taylor
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Aug 2019 |
22,500 |
517,135
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 42.49 per share. |
13 Aug 2019 |
4,000 |
0
(0%)
|
0%
|
42.5 |
169,978
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 41.77 per share. |
13 Aug 2019 |
1,300 |
4,000
(0%)
|
0%
|
41.8 |
54,303
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 40.50 per share. |
13 Aug 2019 |
13,767 |
5,300
(0%)
|
0%
|
40.5 |
557,558
|
Common Stock |
Michael Taylor
|
Director |
Sale of securities on an exchange or to another person at price $ 39.47 per share. |
13 Aug 2019 |
3,433 |
19,067
(0%)
|
0%
|
39.5 |
135,502
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 39.24 per share. |
13 Aug 2019 |
11,513 |
13,487
(0%)
|
0%
|
39.2 |
451,798
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Aug 2019 |
25,000 |
88,408
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 42.90 per share. |
13 Aug 2019 |
100 |
0
(0%)
|
0%
|
42.9 |
4,290
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 42.05 per share. |
13 Aug 2019 |
700 |
100
(0%)
|
0%
|
42.1 |
29,435
|
Common Stock |
James Bristol
|
Director |
Sale of securities on an exchange or to another person at price $ 40.50 per share. |
13 Aug 2019 |
12,687 |
800
(0%)
|
0%
|
40.5 |
513,843
|
Common Stock |
James Bristol
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
13 Aug 2019 |
25,000 |
25,000
(0%)
|
0%
|
1.9 |
47,250
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
13 Aug 2019 |
123,107 |
147,607
(0%)
|
0%
|
1.9 |
232,672
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 40.26 per share. |
13 Aug 2019 |
93,395 |
54,212
(0%)
|
0%
|
40.3 |
3,760,344
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 41.33 per share. |
13 Aug 2019 |
29,712 |
24,500
(0%)
|
0%
|
41.3 |
1,227,911
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 42.90 per share. |
13 Aug 2019 |
25,000 |
66,779
(0%)
|
0%
|
42.9 |
1,072,500
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Aug 2019 |
123,107 |
349,571
|
-
|
|
-
|
Stock Option (Right to Buy) |
Susan L. Kelley
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jul 2019 |
24,000 |
24,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Jun 2019 |
177 |
149,258
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
19 Jun 2019 |
177 |
177
(0%)
|
0%
|
1.9 |
335
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 25.00 per share. |
19 Jun 2019 |
177 |
0
(0%)
|
0%
|
25 |
4,425
|
Common Stock |
Patricia L. Allen
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Ross
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Bristol
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward J. Benz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John R. Martin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Dennis L. Walsh
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2019 |
12,000 |
12,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 25.20 per share. |
03 Jun 2019 |
2,100 |
0
(0%)
|
0%
|
25.2 |
52,927
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jun 2019 |
2,100 |
149,435
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
03 Jun 2019 |
2,100 |
2,100
(0%)
|
0%
|
1.9 |
3,969
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2019 |
1,373 |
151,635
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 May 2019 |
100 |
151,535
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 25.00 per share. |
21 May 2019 |
100 |
0
(0%)
|
0%
|
25 |
2,500
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
21 May 2019 |
100 |
100
(0%)
|
0%
|
1.9 |
189
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 25.07 per share. |
21 May 2019 |
1,373 |
0
(0%)
|
0%
|
25.1 |
34,419
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
21 May 2019 |
1,373 |
1,373
(0%)
|
0%
|
1.9 |
2,595
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 May 2019 |
13,500 |
153,008
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 22.93 per share. |
01 May 2019 |
13,500 |
0
(0%)
|
0%
|
22.9 |
309,524
|
Common Stock |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. |
01 May 2019 |
13,500 |
13,500
(0%)
|
0%
|
1.9 |
25,515
|
Common Stock |
Steven L. Hoerter
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Mar 2019 |
22,000 |
22,000
(0%)
|
0%
|
|
0
|
Common Stock |
Steven L. Hoerter
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Mar 2019 |
400,000 |
400,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Steven L. Hoerter
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Mar 2019 |
30,000 |
52,000
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. |
21 Feb 2019 |
24,500 |
24,500
(0%)
|
0%
|
4.0 |
96,775
|
Common Stock |
Daniel L. Flynn
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Feb 2019 |
24,500 |
15,050
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Feb 2019 |
1,500 |
166,508
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas P. Kelly
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 30.00 per share. |
19 Feb 2019 |
1,500 |
0
(0%)
|
0%
|
30 |
45,000
|
Common Stock |